Skip to Main Content

1,867

Views

3

CrossRef citations to date

0

Altmetric

Clinical

Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis tool

Benjamin Rix Brooks1 Carolinas Neuromuscular/ALS-MDA Care Center, Charlotte, NC, USAView further author information

,

Erik P. Pioro2 Section of ALS & Related Disorders, Cleveland Clinic, Cleveland, OH, USAView further author information

,

Danielle Beaulieu3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information

,

Albert A. Taylor3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information

,

Mark Schactman3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information

,

Mike Keymer3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information

,

Wendy Agnese4 Mitsubishi Pharma America, Inc., Jersey City, NJ, USAView further author information

,

Johnna Perdrizet4 Mitsubishi Pharma America, Inc., Jersey City, NJ, USAView further author information

,

Stephen Apple4 Mitsubishi Pharma America, Inc., Jersey City, NJ, USACorrespondence[email protected]
View further author information

&

David L. Ennist3 Origent Data Sciences, Inc., Vienna, VA, USA, andView further author information